675 related articles for article (PubMed ID: 8264066)
1. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
[TBL] [Abstract][Full Text] [Related]
2. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
[TBL] [Abstract][Full Text] [Related]
3. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
4. New York City injection drug users' memories of syringe-sharing patterns and changes during the peak of the HIV/AIDS epidemic.
Rockwell R; Joseph H; Friedman SR
AIDS Behav; 2006 Nov; 10(6):691-8. PubMed ID: 16708274
[TBL] [Abstract][Full Text] [Related]
5. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.
Des Jarlais DC; Perlis T; Friedman SR; Deren S; Chapman T; Sotheran JL; Tortu S; Beardsley M; Paone D; Torian LV; Beatrice ST; DeBernardo E; Monterroso E; Marmor M
Am J Public Health; 1998 Dec; 88(12):1801-6. PubMed ID: 9842377
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
7. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
8. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
[TBL] [Abstract][Full Text] [Related]
9. Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?
Rockwell R; Deren S; Goldstein MF; Friedman SR; Des Jarlais DC
J Urban Health; 2002 Mar; 79(1):136-46. PubMed ID: 11937622
[TBL] [Abstract][Full Text] [Related]
10. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999.
Maslow CB; Friedman SR; Perlis TE; Rockwell R; Des Jarlais DC
Am J Public Health; 2002 Mar; 92(3):382-4. PubMed ID: 11867315
[TBL] [Abstract][Full Text] [Related]
11. Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005-2012.
Neaigus A; Reilly KH; Jenness SM; Hagan H; Wendel T; Gelpi-Acosta C; Marshall DM
J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3(Suppl 3):S325-S332. PubMed ID: 28604434
[TBL] [Abstract][Full Text] [Related]
12. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.
Des Jarlais DC; Arasteh K; Friedman SR
Subst Use Misuse; 2011; 46(2-3):131-9. PubMed ID: 21303233
[TBL] [Abstract][Full Text] [Related]
13. Operating needle exchange programmes in the hills of Thailand.
Gray J
AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
[TBL] [Abstract][Full Text] [Related]
14. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
[TBL] [Abstract][Full Text] [Related]
15. Drug injection rates and needle-exchange use in New York City, 1991-1996.
Marmor M; Shore RE; Titus S; Chen X; Des Jarlais DC
J Urban Health; 2000 Sep; 77(3):359-68. PubMed ID: 10976610
[TBL] [Abstract][Full Text] [Related]
16. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.
Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Torian LV; Beatice S; Semaan S; Friedman SR
Drug Alcohol Depend; 2010 Jun; 109(1-3):154-60. PubMed ID: 20163922
[TBL] [Abstract][Full Text] [Related]
17. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
Hartel DM; Schoenbaum EE
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
[TBL] [Abstract][Full Text] [Related]
18. Differences in HIV risk behavior of injection drug users in New York City by health care setting.
Turner AK; Harripersaud K; Crawford ND; Rivera AV; Fuller CM
AIDS Care; 2013; 25(10):1321-9. PubMed ID: 23451991
[TBL] [Abstract][Full Text] [Related]
19. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997.
Des Jarlais C; Perlis T; Friedman SR; Chapman T; Kwok J; Rockwell R; Paone D; Milliken J; Monterroso E
Am J Public Health; 2000 Jul; 90(7):1112-6. PubMed ID: 10897190
[TBL] [Abstract][Full Text] [Related]
20. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman D; Friedman SR
Drug Alcohol Depend; 2009 Apr; 101(1-2):88-91. PubMed ID: 19108958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
